Here, we review the structural requirements for the interactions of CgA and CgA-fragments with neuropilin-1 and integrins, their biological effects, their mechanisms, and the potential use of compounds targeting these ligand-receptor interactions for cancer diagnosis and therapy. This evidence concerns the gene CGA and cancer.